相似文献
1
From mouse to man: predicting biased effects of beta-blockers in asthma.
Br J Pharmacol. 2016 Jan;173(1):248-9. doi: 10.1111/bph.13335.
2
β-Blockers have differential effects on the murine asthma phenotype.
Br J Pharmacol. 2015 Oct;172(20):4833-46. doi: 10.1111/bph.13253. Epub 2015 Oct 13.
3
Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype.
Pulm Pharmacol Ther. 2017 Oct;46:30-40. doi: 10.1016/j.pupt.2017.07.004. Epub 2017 Jul 17.
4
Say what, beta-blockers for asthma?
Am J Respir Cell Mol Biol. 2008 Mar;38(3):249-50. doi: 10.1165/rcmb.2008-0001ED.
5
[The effects of different beta blockers on the expiratory flow of the asthmatic].
Therapie. 1976 Sep-Oct;31(5):595-603.
6
[How selective are cardioselective beta-receptor blockers?].
Dtsch Med Wochenschr. 1995 Jan 5;120(1-2):45-6.
7
Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma.
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4948-53. doi: 10.1073/pnas.0400452101.
8
Getting to the heart of asthma: can "beta blockers" be useful to treat asthma?
Pharmacol Ther. 2007 Sep;115(3):360-74. doi: 10.1016/j.pharmthera.2007.04.009. Epub 2007 Jun 8.
9
Asthma and beta-blockers.
Eur J Clin Pharmacol. 1982;22(6):501-9. doi: 10.1007/BF00609622.
10
Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma.
Ann Intern Med. 1991 Aug 15;115(4):270-6. doi: 10.7326/0003-4819-115-4-270.
引用本文的文献
1
G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.
Pharmacol Rev. 2020 Jan;72(1):1-49. doi: 10.1124/pr.118.016899.
2
Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al.
Br J Pharmacol. 2016 Jan;173(1):250-1. doi: 10.1111/bph.13334.
本文引用的文献
1
β-Blockers have differential effects on the murine asthma phenotype.
Br J Pharmacol. 2015 Oct;172(20):4833-46. doi: 10.1111/bph.13253. Epub 2015 Oct 13.
2
Usefulness of impulse oscillometry for the assessment of airway hyperresponsiveness in mild-to-moderate adult asthma.
Ann Allergy Asthma Immunol. 2015 Jul;115(1):17-20. doi: 10.1016/j.anai.2015.04.022.
3
The inverse agonist propranolol confers no corticosteroid-sparing activity in mild-to-moderate persistent asthma.
Clin Sci (Lond). 2014 Dec;127(11):635-43. doi: 10.1042/CS20140249.
4
The Concise Guide to PHARMACOLOGY 2013/14: enzymes.
Br J Pharmacol. 2013 Dec;170(8):1797-867. doi: 10.1111/bph.12451.
5
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.
Nucleic Acids Res. 2014 Jan;42(Database issue):D1098-106. doi: 10.1093/nar/gkt1143. Epub 2013 Nov 14.
6
Randomized placebo-controlled trial to evaluate chronic dosing effects of propranolol in asthma.
Am J Respir Crit Care Med. 2013 Jun 15;187(12):1308-14. doi: 10.1164/rccm.201212-2206OC.
7
Response to salbutamol in patients with mild asthma treated with nadolol.
Eur Respir J. 2010 Oct;36(4):963-5. doi: 10.1183/09031936.00003210.
8
The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.
Pulm Pharmacol Ther. 2008;21(1):134-41. doi: 10.1016/j.pupt.2007.07.002. Epub 2007 Jul 17.
Zotero 插件